Author

S. E. Stimpson

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

B. N. Newby· 2 shared C. E. Mathews· 2 shared J. Chen· 2 shared A. Savinov· 1 shared D. Egli· 1 shared D. J. Perry· 1 shared D. V. Serreze· 1 shared H. D. Chapman· 1 shared

Activity by Year

2020-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

B. N. Newby

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Use of Induced Pluripotent Stem Cells to Build Isogenic Systems and Investigate Type 1 Diabetes

L. H. Armitage, S. E. Stimpson, K. E. Santostefano, L. Sui, S. O. Ogundare, B. N. Newby, R. Castro-Gutierrez, M. K. Huber, J. P. Taylor, P. Sharma, I. Radichev, D. J. Perry, N. Fredette, A. Savinov, N. Terada, , C. E. Mathews

This paper demonstrates the use of induced pluripotent stem cells to create an isogenic system for studying genetic influences on cell-cell interactions in type 1 diabetes.

bioRxiv · May 3, 2021Immunology

Human CD8+ T-cells Require Glycolysis to Elicit Effector Function

S. E. Stimpson, J. Chen, B. N. Newby, R. Khattri, H. D. Chapman, T. E. Angelini, M. E. Merritt, D. V. Serreze, C. E. Mathews

This study shows glycolysis is essential for CD8+ T-cell effector function, while mitochondrial respiration is not, and inhibiting glycolysis reduces autoimmunity in a diabetes model.

bioRxiv · Feb 5, 2020 · PreprintImmunology